The library will operate on a duty schedule between 22 December 2025 and 4 January 2026. During this period, it will be possible to upload publications, but all other services will be suspended.
Adlam, D.,
Zarebinski, M.,
Uren, N. G.,
Ptaszynski, P.,
Oldroyd, K. G.,
Munir, S.,
Zaman, A.,
Contractor, H.,
Kiss, R. G.,
Édes, I.,
Szachniewicz, J.,
Nagy, G. G.,
Garcia, M. J.,
Tomcsányi, J.,
Irving, J.,
Sharp, A. S. P.,
Musialek, P.,
Lupkovics, G.,
Shirodaria, C.,
Selvanayagam, J. B.,
Quinn, P.,
Ng, L.,
Roth, M.,
Insko, M. A.,
Haber, B.,
Hill, S.,
Siegel, L.,
Tulloch, S.,
Channon, K.:
A Randomized, double-blind, dose ranging clinical trial of intravenous FDY-5301 in acute STEMI patients undergoing primary PCI.
Int. J. Cardiol. 347, 1-7, 2022.
von Lewinski, D.,
Benedikt, M.,
Alber, H.,
Debrauwere, J.,
Smits, P. C.,
Édes, I.,
Kiss, R. G.,
Merkely, B.,
Nagy, G. G.,
Ptaszynski, P.,
Zarebinski, M.,
Kubica, J.,
Kleinrok, A.,
Coats, A.,
Wallner, M.:
Dutogliptin in Combination with Filgrastim in Early Recovery Post-Myocardial Infarction-The REC-DUT-002 Trial.
J Clin Med. 11 (19), 1-12, (article identifier: 5728), 2022.
Noc, M.,
Laanmets, P.,
Neskovic, A. N.,
Petrovic, M.,
Stanetic, B.,
Aradi, D.,
Kiss, R. G.,
Ungi, I.,
Merkely, B.,
Hudec, M.,
Blaskó, P.,
Horváth, I.,
Davies, J. R.,
Vukcevic, V.,
Holzer, M.,
Metzler, B.,
Witkowski, A.,
Erglis, A.,
Fister, M.,
Nagy, G. G.,
Bulum, J.,
Édes, I.,
Peruga, J. Z.,
Sredniawa, B.,
Erlinge, D.,
Keeble, T. R.:
A multicentre, prospective, randomised controlled trial to assess the safety and effectiveness of cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarction: the COOL AMI EU Pivotal Trial.
EuroIntervention. 17 (6), 466-473, 2021.
Umar, M. A. J.,
Dabbas, D. A. N. K.,
Borbély, A.,
Fagyas, M.,
Édes, I.,
Csanádi, Z.,
Papp, Z.,
Tóth, A.:
Endogenous regulation of neprilysin activity in the human blood.
In: "PROCEEDINGS OF THE EFOP-3.6.2- 16-2017-00006 (LIVE LONGER) PROJECT". Ed.: Rakonczay Zoltán, Kiss Lóránd, Szegedi Tudományegyetem, Szeged, 80, 2020.
Papp, Z.,
Agostoni, P.,
Alvarez, J.,
Bettex, D.,
Bouchez, S.,
Brito, D.,
Cerny, V.,
Comin-Colet, J.,
Crespo-Leiro, M. G.,
Delgado, J. F.,
Édes, I.,
Eremenko, A. A.,
Farmakis, D.,
Fedele, F.,
Fonseca, C.,
Fruhwald, S.,
Girardis, M.,
Guarracino, F.,
Harjola, V. P.,
Heringlake, M.,
Herpain, A.,
Heunks, L. M. A.,
Husebye, T.,
Ivancan, V.,
Karason, K.,
Kaul, S.,
Kivikko, M.,
Kubica, J.,
Masip, J.,
Matskeplishvili, S.,
Mebazaa, A.,
Nieminen, M. S.,
Oliva, F.,
Papp, G. J.,
Parissis, J.,
Parkhomenko, A.,
Põder, P.,
Pölzl, G.,
Reinecke, A.,
Ricksten, S. E.,
Riha, H.,
Rudiger, A.,
Sarapohja, T.,
Schwinger, R. H. G.,
Toller, W.,
Tritapepe, L.,
Tschöpe, C.,
Wikström, G.,
von Lewinski, D.,
Vrtovec, B.,
Pollesello, P.:
Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use.
Card. Fail. Rev. 6, 1-16, (article identifier: 19), 2020.
Papp, Z.,
Agostoni, P.,
Alvarez, J.,
Bettex, D.,
Bouchez, S.,
Brito, D.,
Cerny, V.,
Comin-Colet, J.,
Crespo-Leiro, M. G.,
Delgado, J. F.,
Édes, I.,
Eremenko, A. A.,
Farmakis, D.,
Fedele, F.,
Fonseca, C.,
Fruhwald, S.,
Girardis, M.,
Guarracino, F.,
Harjola, V. P.,
Heringlake, M.,
Herpain, A.,
Heunks, L. M. A.,
Husebye, T.,
Ivancan, V.,
Karason, K.,
Kaul, S.,
Kivikko, M.,
Kubica, J.,
Masip, J.,
Matskeplishvili, S.,
Mebazaa, A.,
Nieminen, M. S.,
Oliva, F.,
Papp, G. J.,
Parissis, J.,
Parkhomenko, A.,
Põder, P.,
Pölzl, G.,
Reinecke, A.,
Ricksten, S. E.,
Riha, H.,
Rudiger, A.,
Sarapohja, T.,
Schwinger, R. H. G.,
Toller, W.,
Tritapepe, L.,
Tschöpe, C.,
Wikström, G.,
von Lewinski, D.,
Vrtovec, B.,
Pollesello, P.:
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use.
J. Cardiovasc. Pharmacol. 76 (1), 4-22, 2020.
Q1
Biochemistry, Genetics and Molecular Biology (miscellaneous)
D1
Medicine (miscellaneous)
22.
Pápai, G.,
Csató, G.,
Rácz, I.,
Szabó, G. T.,
Bárány, T.,
Rácz, Á.,
Szokol, M.,
Sármán, B.,
Édes, I. F.,
Czuriga, D.,
Kolozsvári, R.,
Édes, I.:
The transtelephonic electrocardiogram-based triage is an independent predictor of decreased hospital mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
J. Telemed. Telecare. 26 (4), 216-222, 2020.